Due to a combination of a falling share price and several years of EPS growth, CLS's stock has de-rated form close to 50x to high-20 times P/E multiple (mid-20x if R&D expense is normalised).
That, combined with EPS growing in the high-teens means the multi-year under-performance of the stock has finally run its course, I think.
It's Hammer Time.
Ann: Shareholder Information Meetings, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.92 |
Change
-1.390(0.45%) |
Mkt cap ! $148.8B | |||
| Open | High | Low | Value | Volume |
| $308.98 | $310.00 | $307.01 | $79.62M | 258.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 845 | $307.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.94 | 307 | 1 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |